Literature DB >> 6850990

Characterization of drug-metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet.

A Aström, J W DePierre, L Eriksson.   

Abstract

A number of drug-metabolizing systems were measured in hyperplastic noduli from the livers of rats receiving 2-acetyl-aminofluorene in their diet and compared with corresponding activities in control liver. The level of microsomal cytochrome P-450 is reduced 54% in the nodular tissue, while 5 activities catalyzed by the cytochrome P-450 system (i.e., aminopyrine N-demethylase, benzo[a]pyrene monooxygenase, ethoxyresorufin O-deethylase, ethoxycoumarin O-deethylase, and 2-acetylaminofluorene N-hydroxylase) are all present at levels corresponding to 5-44% of the control levels. The pattern of 2-acetylaminofluorene metabolites formed by nodule microsomes also differs from the pattern observed with control microsomes. Microsomal epoxide hydrolase is increased 415%, cytosolic glutathione S-transferases 203-576%, microsomal UDP-glucuronyltransferase activity about 200%, and cytosolic DT-diaphorase 1210% in the nodules. The same changes are seen in nodules of different sizes and in individual nodules of the same size. Finally, of all of these changes only the full increase in epoxide hydrolase can be seen after 1-3 weeks of exposure to 2-acetylaminofluorene.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6850990     DOI: 10.1093/carcin/4.5.577

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  A bipartite suppressor: conjunction of two distinct factor-binding sites is essential for down-regulation in rat epoxide hydrolase gene expression.

Authors:  S Kondo; Y Chou; P N Gertson; K Yokoyama; K Itakura
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 2.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

3.  Regulation of glutathione transferase and DT-diaphorase mRNAs in persistent hepatocyte nodules during chemical hepatocarcinogenesis.

Authors:  C B Pickett; J B Williams; A Y Lu; R G Cameron
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

4.  Profile of drug metabolizing enzymes in the nuclear and microsomal fractions from rat liver nodules and normal liver.

Authors:  G M Pacifici; L C Eriksson; H Glaumann; A Rane
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 5.  The role of conjugation reactions in detoxication.

Authors:  K W Bock; W Lilienblum; G Fischer; G Schirmer; B S Bock-Henning
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

6.  Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

Authors:  K H Cowan; G Batist; A Tulpule; B K Sinha; C E Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 7.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

8.  Chronic liver injury by thioacetamide and promotion of hepatic carcinogenesis.

Authors:  P G Gervasi; V Longo; M Marzano; M Saviozzi; G Malvaldi
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

9.  Expression and inducibility of drug-metabolizing enzymes in preneoplastic and neoplastic lesions of rat liver during nitrosamine-induced hepatocarcinogenesis.

Authors:  H W Kunz; A Buchmann; M Schwarz; R Schmitt; W D Kuhlmann; C R Wolf; F Oesch
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

10.  Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas.

Authors:  C R Fairchild; S P Ivy; T Rushmore; G Lee; P Koo; M E Goldsmith; C E Myers; E Farber; K H Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.